Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y12-receptor

被引:44
作者
Hoffmann, Kristina [1 ]
Sixel, Uta [1 ]
Di Pasquale, Francesca [1 ]
von Kuegelgen, Ivar [1 ]
机构
[1] Univ Bonn, Dept Pharmacol, D-53113 Bonn, Germany
关键词
Platelet P2Y(12)-receptor; Ligand recognition; Site-directed mutagenesis; Cangrelor; Reactive blue-2;
D O I
10.1016/j.bcp.2008.08.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The P2Y(12)-receptor plays a prominent role in ADP-induced platelet aggregation. In the present study, we searched for amino acid residues involved in ligand recognition of the human P2Y(12)-receptor. Wild-type or mutated receptors were expressed in 1321N1 astrocytoma cells and Chinese hamster ovary (CHO) cells. There were no major differences in cellular expression of the constructs. Cellular CAMP production and CAMP response element (CRE)-dependent luciferase expression was increased by isoproterenol (astrocytoma cells) or forskolin (CHO cells). In cells expressing wild-type receptors, R256K or S101A mutant constructs, 2-methylthio-ADP inhibited the induced CAMP production with IC50 concentrations of about 0.3 nM. In cells expressing R256A constructs, the IC50 concentration amounted to 25 nM. In cells expressing H253A/R256A, Y259D and K280A constructs, 2-methylthio-ADP failed to affect the cellular CAMP production. Moreover, in cells expressing Y259D and K280A constructs, 2-methylthio-ADP did also not change the forskolin-induced CRE-dependent luciferase expression and caused only small increases in the serum response element-dependent luciferase expression. The antagonist cangrelor had similar potencies at wildtype receptors and R256A constructs (apparent pK(b)-value at wild-type receptors: 9.2). In contrast, reactive blue-2 had a lower potency at the R256A construct (apparent pK(B)-value at wild-type receptors: 7.6). In summary, the data indicate the involvement of Arg256, Tyr259 and, possibly, H253 (transmembrane region TM6) as well as Lys280 (TM7) in the function of the human P2Y12-receptor. Arg256 appears to play a role in the recognition of nucleotide agonists and the non-nucleotide antagonist reactive blue-2, but no role in the recognition of the nucleotide antagonist cangrelor. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1201 / 1213
页数:13
相关论文
共 32 条
[1]   International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy [J].
Abbracchio, Maria P. ;
Burnstock, Geoffrey ;
Boeynaems, Jean-Marie ;
Barnard, Eric A. ;
Boyer, Jose L. ;
Kennedy, Charles ;
Knight, Gillian E. ;
Fumagalli, Marta ;
Gachet, Christian ;
Jacobson, Kenneth A. ;
Weisman, Gary A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :281-341
[2]   DIFFERENTIAL-EFFECTS OF P-2-PURINOCEPTOR ANTAGONISTS ON PHOSPHOLIPASE C-COUPLED AND ADENYLYL CYCLASE-COUPLED P-2Y-PURINOCEPTORS [J].
BOYER, JL ;
ZOHN, IE ;
JACOBSON, KA ;
HARDEN, TK .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) :614-620
[3]   Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding [J].
Cattaneo, M ;
Zighetti, ML ;
Lombardi, R ;
Martinez, C ;
Lecchi, A ;
Conley, PB ;
Ware, J ;
Ruggeri, ZM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1978-1983
[4]  
Cattaneo Marco, 2007, Expert Rev Cardiovasc Ther, V5, P45, DOI 10.1586/14779072.5.1.45
[5]   Identification of a novel human ADP receptor coupled to Gi [J].
Communi, D ;
Gonzalez, NS ;
Detheux, M ;
Brézillon, S ;
Lannoy, V ;
Parmentier, M ;
Boeynaems, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41479-41485
[6]   Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor [J].
Ding, ZG ;
Kim, S ;
Kunapuli, SP .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :338-345
[7]   Central role of the P2Y12 receptor in platelet activation [J].
Dorsam, RT ;
Kunapuli, SP .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) :340-345
[8]   SITE-DIRECTED MUTAGENESIS OF P-2U PURINOCEPTORS - POSITIVELY CHARGED AMINO-ACIDS IN TRANSMEMBRANE HELIX-6 AND HELIX-7 AFFECT AGONIST POTENCY AND SPECIFICITY [J].
ERB, L ;
GARRAD, R ;
WANG, YJ ;
QUINN, T ;
TURNER, JT ;
WEISMAN, GA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4185-4188
[9]   Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets [J].
Garcia, Analia ;
Shankar, Haripriya ;
Murugappan, Swaminathan ;
Kim, Soochong ;
Kunapuli, Satya P. .
BIOCHEMICAL JOURNAL, 2007, 404 (299-308) :299-308
[10]   Evidence for the recognition of non-nucleotide antagonists within the transmembrane, domains of the human P2Y1 receptor [J].
Guo, DP ;
von Kügelgen, I ;
Moro, S ;
Kim, YC ;
Jacobson, KA .
DRUG DEVELOPMENT RESEARCH, 2002, 57 (04) :173-181